Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS' EQUITY (Details Narrative)

v3.25.1
STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 5 Months Ended 7 Months Ended 12 Months Ended
Jan. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Jun. 10, 2024
Dec. 31, 2024
Dec. 31, 2024
Awards to Non-Employee Directors 38,378       5,382  
Share-Based Compensation in Lieu of Cash       4,170 28,826  
Vesting Terms of the Restricted Shares       March 31, 2025 June 10, 2025  
Value of stock issued in exchange for cash compensation       $ 69,827 $ 229,753  
Fair market value per share at grant date       $ 16.74 $ 7.97 $ 7.97
Accrued Compensation for Non-Employee Directors       $ 69,827 $ 124,934  
Description of shares vested immediately on the date of the award   The restricted shares have been issued to Mr. Yaldoo, 2,691 shares vested immediately on the date of the award, 1,345 shares vested on March 11, 2025, and 1,346 shares will vest on the day prior to the 2025 annual stockholder meeting        
Additional shares granted for future services         $ 104,819  
Proceed from stock issuances     $ 130,782      
Shares issued   47,320 407,299      
Private Investors [Member]            
Shares issued     56,666      
Investor Private Placement Member            
Proceed from stock issuances   $ 1,103,376 $ 1,103,376      
Restricted Stock [Member]            
Fair market value of RSAs vested   $ 3,041,387 0      
Weighted average period   1 month 6 days        
Unrecognized compensation expense   $ 294,980       $ 0
Board Of Directors [Member]            
Expenses for options and warrants granted to employees58   600,545 112,104      
Epenses for R and D obligation   40,568 34,648      
Expenses was attributed to G and A   $ 559,977 $ 77,456